MedPath

Acute Effects of Fitness Drink Formulas on Energy Expenditure and Fat Metabolism

Not Applicable
Completed
Conditions
Cognitive Change
Fatigue
Caffeine
Diet, Healthy
Fat Burn
Interventions
Dietary Supplement: Fitness Drink Formula
Registration Number
NCT04455009
Lead Sponsor
University of Central Florida
Brief Summary

The purpose of this investigation was to examine the acute effects of consuming two different fitness drink formulas on the physiological response at rest and to exercise in healthy men and women.

Detailed Description

Thermogenic fitness drinks containing \~200mg of caffeine have been reported to accelerate the metabolism, increase energy, and consequently promote increased fat oxidation. However, determination of the efficacy of lower caffeine concentrations may provide additional options for individuals with preferences for reduced caffeine intake. Therefore, the aim of this study was to evaluate different fitness drink formulas containing a total of 100mg and 140mg of caffeine on the physiological response at rest and to exercise.

This study utilized a randomized, double-blind, placebo-controlled design. All participants completed three testing visits during which they consumed the placebo, the 100mg caffeine formula, and the 140mg caffeine formula. Blood samples, blood pressure, heart rate, resting energy expenditure, substrate oxidation, and neurocognitive assessments were collected at baseline and repeated 30, 60, and 90 minutes post-ingestion. Immediately following the last cognitive assessment, a maximal graded exercise test with gas analysis was conducted on a cycle ergometer to evaluate physical performance and maximal fat oxidation during exercise as well as the physiological response prior to and following exercise.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Young adult men and women between the ages of 18 and 35 years old.
  • Participant is deemed by the investigator to be healthy and free of any physical limitations determined by physical activity readiness questionnaire (PAR-Q+) and medical and activity history questionnaire (MHQ).
  • Participants will be required to be recreationally-active (defined according to American College of Sports Medicine standards of at least 150 minutes exercise per week and verified by information provided in the MHQ).
  • Participant is willing to abstain from dietary supplementation throughout the duration of the study as indicated in the Informed Consent.
  • Participant understands the study procedures and signs forms providing informed consent to participate in the study.
Exclusion Criteria
  • Inability to perform physical exercise, as determined by the PAR-Q+.
  • Any "Yes" response in the PAR-Q+.
  • History of hypertension, metabolic, hepatorenal, musculoskeletal, autoimmune or neurological disease, as determined by the MHQ.
  • Regular consumption of greater than 250 mg per day of caffeine
  • Currently taking thyroid, antihyperlipidemic, hypoglycemic, anti-hypertensive or androgenic medications.
  • Taking any other nutritional supplement or performance-enhancing drug (determined from MHQ) that may interfere with the outcome variables of the study.
  • Pregnancy (determined from MHQ).

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
140mg Caffeine FormulaFitness Drink Formula10kcal drink containing a total of 140 mg of caffeine from a proprietary blend of caffeine, guarana, ginger, and green tea extract containing epigallocatechin gallate
100mg Caffeine FormulaFitness Drink Formula10kcal drink containing a total of 100 mg of caffeine from a proprietary blend of caffeine, guarana, ginger, and green tea extract containing epigallocatechin gallate
Placebo FormulaFitness Drink Formulanon-caloric/non-caffeinated drink
Primary Outcome Measures
NameTimeMethod
Change in energy expenditure/substrate oxidation in response to exercise>90 min post-ingestion (pre/peri/post maximal graded exercise test)

Estimates from gas exchange analysis via indirect calorimetry

Change in resting serum glycerolBaseline, 30, 60, and 90 min post-ingestion

Obtained from blood draw of the superficial forearm vein

Change in oxygen consumption/carbon dioxide production in response to exercise>90 min post-ingestion (pre/peri/post maximal graded exercise test)

Estimates from gas exchange analysis via indirect calorimetry

Change in resting minute ventilationBaseline, 30, 60, and 90 min post-ingestion

Estimates from gas exchange analysis via indirect calorimetry

Change in minute ventilation in response to exercise>90 min post-ingestion (pre/peri/post maximal graded exercise test)

Estimates from gas exchange analysis via indirect calorimetry

Change in resting energy expenditure/substrate oxidationBaseline, 30, 60, and 90 min post-ingestion

Estimates from gas exchange analysis via indirect calorimetry

Secondary Outcome Measures
NameTimeMethod
Change in resting blood pressure responseBaseline, 30, 60, and 90 min post-ingestion

Measured via automated blood pressure monitor

Change in heart rate/heart rate variability in response to exercise>90 min post-ingestion (pre/peri/post maximal graded exercise test)

Measured via chest-based heart rate monitor

Change in Automated Neuropsychological Assessment Metrics (ANAM) screeningBaseline, 30, 60, and 90 min post-ingestion

Measures from mood scale, go/no go test, Stroop test

Change in resting heart rate/heart rate variabilityBaseline, 30, 60, and 90 min post-ingestion

Measured via chest-based heart rate monitor

Change in power output>90 min post-ingestion

Obtained via cycle ergometer during the maximal graded exercise test

Trial Locations

Locations (1)

Kinesiology Laboratories

🇺🇸

Orlando, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath